Tracking a promising treatment for a painful skin condition

NCT ID NCT06517732

Recruiting now Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study aims to see how well the drug secukinumab works for adults with moderate to severe hidradenitis suppurativa (HS) in real-world medical settings. It will follow 300 patients in Russia who are already starting this treatment as part of their normal care. Researchers will track how much the painful skin lumps and tunnels improve and how the treatment is used alongside other therapies.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Locations

Novartis Investigative Site
RECRUITING

Izhevsk, 426039, Russia
Novartis Investigative Site
RECRUITING

Kaliningrad, 236016, Russia
Novartis Investigative Site
RECRUITING

Kaliningrad, 236029, Russia
Novartis Investigative Site
RECRUITING

Kazan', 420012, Russia
Novartis Investigative Site
RECRUITING

Kemerovo, 650025, Russia
Novartis Investigative Site
RECRUITING

Krasnodar, 350020, Russia
Novartis Investigative Site
RECRUITING

Moscow, 107076, Russia
Novartis Investigative Site
WITHDRAWN

Moscow, 119049, Russia
Novartis Investigative Site
RECRUITING

Moscow, 119881, Russia
Novartis Investigative Site
RECRUITING

Moscow, 123182, Russia
Novartis Investigative Site
RECRUITING

Moscow, 129110, Russia
Novartis Investigative Site
RECRUITING

Nizhny Novgorod, 603950, Russia
Novartis Investigative Site
RECRUITING

Penza, 440052, Russia
Novartis Investigative Site
RECRUITING

Saint Petersburg, 197022, Russia
Novartis Investigative Site
RECRUITING

Samara, 443079, Russia
Novartis Investigative Site
RECRUITING

Saratov, 410028, Russia
Novartis Investigative Site
RECRUITING

Stavropol, 355020, Russia
Novartis Investigative Site
RECRUITING

Tula, 300053, Russia
Novartis Investigative Site
RECRUITING

Ufa, 450010, Russia
Novartis Investigative Site
RECRUITING

Yakutsk, 677000, Russia

Conditions

Explore the condition pages connected to this study.

HIDRADENITIS SUPPURATIVA